-
Looking Back on 10 Years Since the Commencement of Free Provision of DEC Tablets
-
New Innovation Page Launch
-
March 28, 2024
-
March 28, 2024
-
March 25, 2024
Notice of the Settlement of Patent Infringement Litigation Related to Lenvatinib in the U.S.
-
March 22, 2024
-
March 21, 2024
-
March 27, 2024
-
March 11, 2024
-
March 7, 2024
-
February 7, 2024
-
February 6, 2024
IR “Third Quarter Financial Report for the Fiscal Year Ending March 31, 2024”
-
October 13, 2023
-
March 9, 2023
Warning Against Solicitation, Fraudulent Emails, etc. that Use the Name of Eisai or Related Parties
-
February 17, 2023
EISAI SUPPORTS RELIEF EFFORTS FOR EARTHQUAKE IN TURKEY AND SYRIA
-
July 15, 2022
Notification Regarding U.S. Research and Development Subsidiary
-
April 1, 2022
Sustainability
30 countries 2.28 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of February 2024)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries